Equitable Holdings, Inc. Agios Pharmaceuticals, Inc. Transaction History

Equitable Holdings, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$29.58 - $49.78 $207,060 - $348,460	-7,000 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$41.92 - $58.18 $41,920 - $58,180	-1,000 Reduced 12.5%	7,000 $323,000
Q1 2021 May 14, 2021	BUY	$44.23 - $57.5 $44,230 - $57,500	1,000 Added 14.29%	8,000 $413,000
Q3 2020 Nov 13, 2020	SELL	$33.87 - $55.93 $541,920 - $894,880	-16,000 Reduced 69.57%	7,000 $245,000
Q2 2020 Aug 13, 2020	BUY	$34.45 - $53.48 $68,900 - $106,960	2,000 Added 9.52%	23,000 $1.23 Million
Q1 2020 May 15, 2020	SELL	$31.52 - $53.81 $94,560 - $161,430	-3,000 Reduced 12.5%	21,000 $745,000
Q4 2019 Feb 18, 2020	BUY	$30.08 - $50.59 $721,920 - $1.21 Million	24,000 New	24,000 $1.15 Million

244

59.9M

270K

332K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $1.84B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Equitable Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Equitable Holdings, Inc. with notifications on news.